SecBot SecBot
Home › SEC Filings

SEC Filing Analysis

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
HTOO6-K, PRESS-RELEASEneutral4/10Fusion Fuel announced its Al Shola Gas subsidiary has 87 LPG engineering contracts valued at $5.2 million, with 74% alreOct 28, 2026
EATPRESS-RELEASEbullish6/10Brinker International reported Q1 fiscal 2027 adjusted EPS of $2.77, beating the $2.45 consensus by 13.1%, and revenue oOct 28, 2026
BENF8-Kneutral4/10Beneficient filed a motion to intervene in Delaware Court of Chancery litigation against HCLP Nominees, seeking to invalOct 28, 2026
AMBRSC 13D/Aneutral3/10Yuao Wu (Chairman and CEO of Amber International Holding Ltd) filed Amendment No. 2 to his Schedule 13D, adding Mars WayOct 28, 2026
HOPE8-Kneutral5/10Hope Bancorp reported Q3 2026 net income of $35.6M ($0.28 diluted EPS), up 8% QoQ and 16% YoY, driven by loan growth, NIOct 28, 2026
ENVX8-Kneutral5/10Enovix declared a warrant dividend, distributing approximately 65.6 million warrants at a ratio of 1 warrant per 4 shareOct 28, 2026
WING8-Kbearish6/10Wingstop reported Q3 2026 revenue of $185.1M (+5.3% YoY) and GAAP EPS of $1.07, missing the consensus estimate of $1.02 Oct 28, 2026
FCEL8-Kneutral3/10FuelCell Energy appointed Peter Hopper, a digital infrastructure and data center investment veteran, to its board of dirOct 28, 2026
WB6-Kneutral2/10Weibo Corporation filed a 6-K announcing that its board will meet on November 17, 2026 to approve and publish its unaudiOct 28, 2026
BTI6-Kneutral2/10British American Tobacco announced the appointment of Bruce Sewell, former Apple General Counsel, as an independent Non-Oct 28, 2026
KCHVDEFA14Aneutral5/10Kochav Defense Acquisition Corp. filed additional definitive proxy soliciting materials (DEFA14A) amending the terms of Oct 28, 2026
JLL8-Kbullish6/10JLL reported record Q3 2026 diluted EPS of $6.85, up 49% YoY, and adjusted diluted EPS of $6.76, up 50% YoY, both above Oct 28, 2026
KCHV8-Kneutral4/10Kochav Defense Acquisition Corp. filed an 8-K updating the terms of its proposed extension vote. The sponsor will now coOct 28, 2026
BLDPPRESS-RELEASEneutral3/10Ballard Power Systems announced the launch of the HPU Agile-H, a 80kW towable hydrogen power unit developed by its subsiOct 28, 2026
FTV8-Kbullish6/10Fortive Q3 2026 revenue of $1.108B grew 7.8% YoY (core +7.2%), beating the $1.07B consensus. Adjusted EPS of $0.77 beat Oct 28, 2026
HYFMPRESS-RELEASEbearish6/10Hydrofarm closed a registered direct offering and concurrent private placement raising approximately $8.3 million in groOct 28, 2026
KCHVUPRESS-RELEASEneutral3/10Kochav Defense Acquisition Corp. announced that its sponsor will contribute cash to the trust account to extend the deadOct 28, 2026
FEIMPRESS-RELEASEbullish5/10Frequency Electronics announced multiple U.S. Government contract awards totaling approximately $12 million for space anOct 28, 2026
MGPI8-Kbearish5/10MGP Ingredients reported Q3 2026 results with sales of $117.9M (down 10% YoY) and GAAP EPS of $0.32, in line with the coOct 28, 2026
ENVXPRESS-RELEASEneutral5/10Enovix declared a one-for-four warrant dividend (exercise price $3.00) to common stockholders and convertible note holdeOct 28, 2026
SIGAPRESS-RELEASEneutral3/10SIGA Technologies announced a new contract from the Canadian Department of National Defence for oral TPOXX (tecovirimat)Oct 28, 2026
REKRPRESS-RELEASEneutral4/10Rekor Systems announced a 94% increase in its FDOT contract ceiling from $4.9M to $9.5M, and a new RTC contract in NevadOct 28, 2026
JLLPRESS-RELEASEbullish6/10JLL reported Q3 2026 adjusted EPS of $6.76, beating the $6.18 consensus by 9.4%, and revenue of $7.28B, slightly above tOct 28, 2026
SYBTPRESS-RELEASEbullish6/10Stock Yards Bancorp reported record Q3 2026 net income of $43.5M ($1.40 diluted), beating consensus EPS of $1.35 by 3.7%Oct 28, 2026
PVLAPRESS-RELEASEbullish7/10Palvella Therapeutics announced FDA acceptance and Priority Review of its NDA for QTORIN rapamycin for microcystic lymphOct 28, 2026
MGN6-Kneutral4/10Megan Holdings Ltd. disclosed in a 6-K filing that two putative securities class actions were filed against it in July 2Oct 28, 2026
PVLA8-Kbullish6/10Palvella Therapeutics announced that the FDA has accepted its NDA for QTORIN 3.9% rapamycin anhydrous gel for microcystiOct 28, 2026
SYBT8-Kbullish6/10Stock Yards Bancorp reported record Q3 2026 net income of $43.5M ($1.40 diluted), up from $36.2M ($1.23) a year ago, driOct 28, 2026
EXTR8-Kbullish6/10Extreme Networks reported Q1 FY2027 revenue of $341.1M, up 10% YoY, and non-GAAP EPS of $0.33, up 50% YoY, with SaaS ARROct 28, 2026
CMRE6-Kbearish4/10Costamare Inc. reported Q3 2026 results with voyage revenue down 1.8% YoY to $212.1 million and net income from continuiOct 28, 2026
« Previous Page 23 of 334 Next »